Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2026-01-09 @ 12:14 AM
Study NCT ID:
NCT00844805
Status:
COMPLETED
Last Update Posted:
2017-04-12
First Post:
2009-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-13
First Submit QC Date:
None
Study First Post Date:
2009-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-09-20
Results First Submit QC Date:
None
Results First Post Date:
2012-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-15
Last Update Post Date:
2017-04-12
Last Update Post Date Type:
ACTUAL